Evidence pushes back on FDA's use of surrogate markers: report

A recent report shows that there is little evidence backing the FDA's use of surrogate markers to determine if a medicine is fit for approval.

Related Keywords

Sarepta Duchenne ,Joseph Ross ,Emory University ,Yale School Of Medicine ,Yale School Of Public Health ,Yale School ,